The latest tariff announcement by U.S. President Donald Trump has raised concerns across global markets, with duties on certain patented and branded medicines being raised up to 100 percent. While the move is seen as a sharp escalation in trade measures, industry experts and government
Saurav Ojha, Co-Founder, Iberia Pharmaceuticals Indian skincare has long borrowed its science from European and other Western countries. However, the formulations that work for their genetic makeup, skin type, weather, sun and pollution exposure is vastly different from Indian skin. In the Indian subcontinent we have
Saurav Ojha, Co-Founder, Iberia PharmaceuticalsIndia’s skincare narrative is changing, that too at a fast pace. Contrary to earlier experiences, customers are now demanding products that can enhance, rather than ‘fix’ their skin. They are gravitating towards companies that are moving away from superficial branding
In a major breakthrough for India’s medical device sector, the government has stepped in to avert a looming healthcare and supply chain crisis The intervention, led by the Department of Pharmaceuticals (DoP) and the Ministry of Steel, comes as a major relief to manufacturers grappling
Built to global quality and sustainability standards, Iberia’s facility is a key unit under ‘Make-In-India’ movementThe company has invested around 70 crores in this world class manufacturing and research facilityIberia Pharmaceuticals, a leading name in skincare, is proud to announce its new hi-tech manufacturing and
Ravishankar Gopalakrishnan, Group Chief Operating Officer & Wholetime Director, Medikabazaar penned down:India’s healthcare ecosystem is evolving rapidly, and with it comes an urgent need to modernise the medical logistics infrastructure that supports it. According to a report by Grand View Research, the healthcare supply chain
Torrent Pharmaceuticals Ltd. (NSE: TORNTPHARM / BSE: 500420) has announced the launch of Shelcal® Total, a scientifically formulated adult nutrition supplement powder that expands its flagship Shelcal® brand into the rapidly growing Nutrition segment.Shelcal®—with a three-decade legacy of trust—has remained India’s #1 calcium supplement brand
According to CareEdge Ratings, India’s orthopaedic and cardiac implant sector, including exports, which stood at ~$2.4 to $2.7 billion in FY24, is expected to reach ~$4.5 to $5.0 billion by FY28, driven by strong domestic demand and gradually growing export presence. Foreign MNCs, with their long
Now Pharma Inc., a leading Indian pharmaceutical company, acknowledges the recent statements by U.S. President Donald Trump regarding the introduction of new tariffs on pharmaceuticals. The proposed tariffs aim to impose unprecedented levels of duties on pharmaceutical imports, creating uncertainty within the global pharmaceutical industry.
Government’s Initiative to Reduce Import Dependence on China and Boost Domestic API ManufacturingThe Government of India is taking decisive steps to enhance domestic manufacturing of Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), and Drug Intermediates (DIs) through the Production Linked Incentive (PLI) Scheme. This
